Modest Spleen Shrinkage Plus Transfusion Freedom Predicts Longer Survival in Myelofibrosis Patients on Momelotinib
Post hoc analyses of the SIMPLIFY-1 and MOMENTUM phase 3 trials show that myelofibrosis patients treated with momelotinib who achieve ...
